Alligator Bioscience: BioStock: Alligator's mitazalimab data published in The Lancet Oncology
Alligator Bioscience's phase II data with cancer immunotherapy mitazalimab have been published in The Lancet Oncology - one of the most prestigious and internationally trusted scientific journals in the world. BioStock spoke with Alligator's CEO Søren Bregenholt to get his reaction.
Read the article at biostock.se:
Alligator's mitazalimab data published in The Lancet Oncology - BioStock (https://www.biostock.se/en/2024/06/alligators-mitazalimab-data-published-in-the-lancet-oncology/)
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/